Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas S Harrison

Showing results (61-70 of 174) with videos related to

Pageof 18
Sort By:
BMC Infectious Diseases|August 2, 2020
Determine TB-LAM point-of-care tuberculosis assay predicts poor outcomes in outpatients during their first year of antiretroviral therapy in South AfricaAndrew D Kerkhoff, Nicky Longley, Nicola Kelly, et al.
Antimicrobial Agents and Chemotherapy|May 10, 2023
Heightened Efficacy of Anidulafungin When Used in Combination with Manogepix or 5-Flucytosine against Candida auris <i>In Vitro</i>Larissa L H John, Darren D Thomson, Tihana Bicanic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2011
Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitisJoseph N Jarvis, Ann Percival, Sean Bauman, et al.
The Journal of Infection|November 18, 2006
Immune dysfunction in HIV-seronegative, Cryptococcus gattii meningitisAnnemarie E Brouwer, Asna A Siddiqui, Maartje I Kester, et al.
BMC Infectious Diseases|October 18, 2018
Ischemic stroke as a complication of cryptococcal meningitis and immune reconstitution inflammatory syndrome: a case reportJayne P Ellis, Newton Kalata, Elizabeth C Joekes, et al.
The Journal of Infectious Diseases|July 20, 2005
Baseline correlation and comparative kinetics of cerebrospinal fluid colony-forming unit counts and antigen titers in cryptococcal meningitisAnnemarie E Brouwer, Paprit Teparrukkul, Supraphada Pinpraphaporn, et al.
Social Science & Medicine (1982)|June 1, 2022
Decision making in a clinical trial for a life-threatening illness: Therapeutic expectation, not misconceptionDavid S Lawrence, Agnes Ssali, Neo Moshashane, et al.
Plos Neglected Tropical Diseases|October 24, 2022
The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and UgandaDavid S Lawrence, Agnes Ssali, Neo Moshashane, et al.
Plos Pathogens|April 9, 2015
Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitisJoseph N Jarvis, Graeme Meintjes, Tihana Bicanic, et al.
The Journal of Infectious Diseases|March 16, 2013
The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitisJoseph N Jarvis, Joseph P Casazza, Hunter H Stone, et al.
Pageof 18

Showing results (61-70 of 174) with videos related to

Sort By:
Pageof 18
BMC Infectious Diseases|August 2, 2020
Determine TB-LAM point-of-care tuberculosis assay predicts poor outcomes in outpatients during their first year of antiretroviral therapy in South AfricaAndrew D Kerkhoff, Nicky Longley, Nicola Kelly, et al.
Antimicrobial Agents and Chemotherapy|May 10, 2023
Heightened Efficacy of Anidulafungin When Used in Combination with Manogepix or 5-Flucytosine against Candida auris <i>In Vitro</i>Larissa L H John, Darren D Thomson, Tihana Bicanic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2011
Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitisJoseph N Jarvis, Ann Percival, Sean Bauman, et al.
The Journal of Infection|November 18, 2006
Immune dysfunction in HIV-seronegative, Cryptococcus gattii meningitisAnnemarie E Brouwer, Asna A Siddiqui, Maartje I Kester, et al.
BMC Infectious Diseases|October 18, 2018
Ischemic stroke as a complication of cryptococcal meningitis and immune reconstitution inflammatory syndrome: a case reportJayne P Ellis, Newton Kalata, Elizabeth C Joekes, et al.
The Journal of Infectious Diseases|July 20, 2005
Baseline correlation and comparative kinetics of cerebrospinal fluid colony-forming unit counts and antigen titers in cryptococcal meningitisAnnemarie E Brouwer, Paprit Teparrukkul, Supraphada Pinpraphaporn, et al.
Social Science & Medicine (1982)|June 1, 2022
Decision making in a clinical trial for a life-threatening illness: Therapeutic expectation, not misconceptionDavid S Lawrence, Agnes Ssali, Neo Moshashane, et al.
Plos Neglected Tropical Diseases|October 24, 2022
The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and UgandaDavid S Lawrence, Agnes Ssali, Neo Moshashane, et al.
Plos Pathogens|April 9, 2015
Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitisJoseph N Jarvis, Graeme Meintjes, Tihana Bicanic, et al.
The Journal of Infectious Diseases|March 16, 2013
The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitisJoseph N Jarvis, Joseph P Casazza, Hunter H Stone, et al.
Pageof 18